Q3 FY2025 Earnings
Financial report interval: 2025.06.30 - 2025.09.30
Overview: Windtree Therapeutics(WINT) the EBIT is -3.752 M (+20.86%);the EPS is -1.08 (+99.49%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B20.86%
----
----
EPS
-1.084899.49%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf